Copeptin Hormone Concentrations in Dogs with Heart Disease and Relationship with Antidiuretic Hormone
Open Access
Abstract
Antidiuretic hormone (ADH) is upregulated in dogs with cardiac disease. However, measurement of ADH is impractical in a clinical setting. Copeptin is co-secreted with ADH, making it a potential biomarker of ADH secretion. We hypothesized that dogs with cardiac disease would upregulate copeptin concentrations and that copeptin would positively correlate with ADH, serum chloride ([Cl−]), and degree of mathematical [Cl−] correction. The study population comprised 19 healthy, 20 preclinical (Stage B), and 20 congestive heart failure (CHF, Stage C or D) dogs. Groups were compared with Kruskal–Wallis tests. The agreement between ADH and copeptin was assessed with Bland–Altman analysis. Relationships between copeptin and clinical variables were explored using multivariable linear regression. There were no significant differences in copeptin concentrations among healthy (median 54.9 pg/mL; range 0.5–196.1), preclinical (median 43.6 pg/mL; range 0.5–131.4), and CHF (median 60.5 pg/mL; range 0.5–997.8) dogs (p = 0.76). Relative to ADH, copeptin showed a negative proportional bias of −87.8 pg/mL with wide limits of agreement (−421.8 to 246.2). Linear regression showed a significant influence of age on copeptin concentration. Copeptin measured by ELISA does not reflect the ADH concentration in healthy dogs or in dogs with cardiac disease. Copeptin concentrations are, however, inversely associated with age.Keywords
Funding Information
- Maggy Spannuth Veterinary Cardiovascular Research Fund from the University of Florida Foundation
This publication has 45 references indexed in Scilit:
- Do Heart Failure Biomarkers Influence Heart Failure Treatment Response?Current Heart Failure Reports, 2023
- Predictive Value of Plasma Copeptin Level in Children with Acute Heart FailurePediatric Cardiology, 2022
- Baseline and incident hypochloremia in chronic heart failure outpatients: Clinical correlates and prognostic roleEuropean Journal of Internal Medicine, 2021
- Dysregulation of the Renin-Angiotensin System and the Vasopressinergic System Interactions in Cardiovascular DisordersCurrent Hypertension Reports, 2018
- Hyponatremia and antidiuresis syndromeAnnales d'Endocrinologie, 2011
- Association of Copeptin and N-Terminal proBNP Concentrations With Risk of Cardiovascular Death in Older Patients With Symptoms of Heart FailureJAMA, 2011
- Incremental Value of Copeptin for Rapid Rule Out of Acute Myocardial InfarctionJACC, 2009
- C-Terminal Provasopressin (Copeptin) is Associated With Left Ventricular Dysfunction, Remodeling, and Clinical Heart Failure in Survivors of Myocardial InfarctionJournal of Cardiac Failure, 2008
- Comparison of Copeptin, B-Type Natriuretic Peptide, and Amino-Terminal Pro-B-Type Natriuretic Peptide in Patients With Chronic Heart FailureJACC, 2008
- Antidiuretic hormone in congestive heart failureThe American Journal of Medicine, 1982